Medicare and Medicaid
Our work in Medicare and Medicaid
-
Study: Shingles Vaccine Uptake Dramatically Increased After Inflation Reduction Act Removes Patient Out-of-Pocket Cost
Researchers from USC and University of Michigan say the study adds to “robust evidence” that eliminating costs helps patients access preventive services
Categorized in -
A Roadmap for Improving Medicare’s Application of Coverage With Evidence Development
CED has the potential to improve access to technologies, promote innovation, and drive evidence generation. However, CMS, manufacturers, researchers, policy makers, patients, and others must first work together.
Categorized in -
Improving Access to Medigap When Beneficiaries Leave Medicare Advantage
For beneficiaries switching from Medicare Advantage, state regulations generally permit Medigap plans to deny coverage, impose waiting periods, or charge higher premiums.
Categorized in -
Medicare Can Follow Blazed Trails to Revitalize Alzheimer’s Care
If Medicare is allowed to step up to the challenge of Alzheimer’s, patients could receive affordable and good quality care as soon as their disease develops.
Categorized in -
Comparative Effectiveness of Placental Allografts in the Treatment of Diabetic Lower Extremity Ulcers and Venous Leg Ulcers in U.S. Medicare Beneficiaries: A Retrospective Observational Cohort Study Using Real-World Evidence
DLEUs and VLUs treated with vCPM and vLPM allografts are associated with lowered 1-year mortality, wound recurrence, and AOs in DLEUs and VLUs compared with standard care. Decision makers weighing coverage of placental allografts should consider these added short- and long-term clinical benefits relative to costly management and high mortality of Medicare’s most frequent wounds.
Categorized in -
Medicare Coverage of Weight Loss Drugs Could Save the U.S. Billions of Dollars
The new weight loss drugs work, and represent huge value in treating obesity. Even though they are expensive, broader access to them via Medicare would end up saving the U.S. money.
Categorized in -
Medicare Part D Plans Increased Restrictions on Drug Coverage
Medicare Part D plans excluded more compounds from coverage or subjected more of them to review before patients can access treatments, USC researchers found.
Categorized in -
Medicare’s Mental Health Care Problem
Mental health care providers are subject to unique constraints and incentives, compared to other specialists.
Categorized in -
Seminar Series – Boris Vabson
Boris Vabson is a research faculty member at Harvard Medical School. His academic research focuses on health insurance payment systems and markets. He is also a nonresident fellow at the USC-Schaeffer Center and a nonresident fellow in health policy at the American Enterprise Institute.
-
Paying for Advance Care Planning in Medicare: Impacts on Care and Spending Near End of Life
Paying for advance care planning services can be promising in improving patients’ quality of life at end of life (EOL) while lowering EOL spending, especially for patients most vulnerable to receiving aggressive EOL care.
Categorized in